Canadians want access to the latest treatments for themselves, and their friends and family, especially for diseases and conditions where limited options are available.
|
OTTAWA, April 25, 2019 /CNW/ - Canadians want access to the latest treatments for themselves, and their friends and family, especially for diseases and conditions where limited options are available. One area that has seen a great deal of change in treatment options is cancer. Based on Canadian Cancer Statistics, 45% of Canadian women and 49% of Canadian men will develop cancer during their lifetime. While treatments are available for many types of cancers, there are some cases where treatment options are limited, such as with rare types of leukemia. In recent months, Health Canada has authorized several new drugs for patients with rare and debilitating cancers, including a new type of therapy called CAR-T cell immunotherapy, which helps provide a customized option for the treatment of an aggressive type of lymphoma. The Department prioritized many of these drug reviews to ensure faster access to treatment options for the people who need them. Medical devices are equally critical for many Canadians to achieve and maintain their health. Health Canada has also licensed new medical devices that test blood, supplement oxygen, stimulate nerves and treat cardiac patients and patients with corneal ulcers. These new drugs and devices have the potential to vastly improve the quality of lives of many Canadians, including children and seniors. As of March 2019, information from drug submissions will be made available to Canadians through Health Canada's new Clinical Information Portal, following the Department's review of each drug submission. Health Canada will also make information about drugs and medical devices already on the market available upon request, and add this information to the portal. Beginning in 2021, the Department will start releasing information on new medical device submissions. Canadians can follow @GovCanHealth on Twitter to find out when Health Canada has authorized new health products. For people who are not yet following us, our recent authorizations are listed below. Drugs and medical devices authorized since January 2019 Drugs for Cancer and Rare Diseases
Drugs for Eye or Skin Disorders
Drugs for Chronic Disease
Drugs for General Use
General and Plastic Surgery Devices
Cardiovascular Health Devices
In Vitro Diagnostic Devices
Additional Health Canada Resources for Information about Drugs and Medical Devices:
SOURCE Health Canada |